David Natan Cyclacel Pharmaceuticals, Inc. (CYCC) insider trading activity

CYCC Quotes by TradingView

David Natan is Director of Cyclacel Pharmaceuticals, Inc.. Currently has a direct ownership of 100,000 shares of CYCC, which is worth approximately $41,000. The most recent transaction as insider was on Jan 02, 2025, when has been sold 100,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 100K
n/a 3M change
n/a 12M change
Total Value Held $41,000

DAVID NATAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2025
BUY
Grant, award, or other acquisition
-
100,000 Added 50.0%
100,000 Common Stock

Also insider at

OPGN
OPGEN INC Healthcare
Director
MINM
MINIM, INC. Technology
Director
TTNP
TITAN PHARMACEUTICALS INC Healthcare
Director
GDMK
Global Diversified Marketing Group Inc. Consumer Defensive
Director
DN

David Natan

Director
Island Park, NY

Track Institutional and Insider Activities on CYCC

Follow Cyclacel Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CYCC shares.

Notify only if

Insider Trading

Get notified when an Cyclacel Pharmaceuticals, Inc. insider buys or sells CYCC shares.

Notify only if

News

Receive news related to Cyclacel Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CYCC